1. Home
  2. PHGE vs SPHL Comparison

PHGE vs SPHL Comparison

Compare PHGE & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$4.20

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$2.64

Market Cap

7.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHGE
SPHL
Founded
2015
2002
Country
United States
Singapore
Employees
57
71
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PHGE
SPHL
Price
$4.20
$2.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$26.00
N/A
AVG Volume (30 Days)
84.7K
50.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.35
52 Week High
$8.50
$25.11

Technical Indicators

Market Signals
Indicator
PHGE
SPHL
Relative Strength Index (RSI) 46.14 41.15
Support Level $0.41 $0.41
Resistance Level $5.99 $5.38
Average True Range (ATR) 0.80 0.44
MACD -0.24 -0.18
Stochastic Oscillator 8.93 6.90

Price Performance

Historical Comparison
PHGE
SPHL

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: